Quality by Design (QbD) revolutionizes generic drug development by integrating science and risk management from the start. Learn how it reduces FDA review times, cuts costs, and improves product quality. Real-world examples and future trends in this detailed guide.
Modern bioequivalence studies must account for age and sex differences to ensure generic drugs work safely for everyone. Learn what the FDA, EMA, and other regulators require today-and why outdated study designs are no longer enough.